MD Biosciences Neuro published part one of a short biomarker series beginning with circulating biomarkers.
Published
Signal category
Research & Knowledge
Quote
“This is part one of a short biomarker series, beginning with circulating biomarkers.”
— MD Biosciences Neuro team
Company
MD Biosciences Neuro
Translational Preclinical Research in Rodent and Large-Animal Models.
- Industry
- Biotechnology Research
- Location
- Cambridge, US
- Company size
- 18 employees
#Preclinical CRO that specializes in #pain and #neurodegenerative diseases. Our Neurological and CNS research services focus on clinically-relevant read outs and endpoints. Specialties include studies of neuropathic pain, and neurodegenerative diseases. Our GLP-certified laboratory is fully equipped with behavioral suites for assessing cognition, memory, pain, sensorimotor function, and more. In addition to rodent models, we offer pig models to further bridge the gap between preclinical and clinical studies. We understand that clinically relavant preclinical data is enhanced by the use of outcomes comparable to those measured in patients. We go beyond the standard behavior analysis by adding methods such as intraepidermal nerve fiber (IENF) staining and electrophysiology.
Founded 1997